Balyasny Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240M | Buy |
|
|||||
|
2025
Q1 | $5.81M | Buy |
|
|||||
|
2024
Q4 | $3.1M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.42M | Sell |
|
|||||
|
2024
Q1 | $2.59M | Sell |
|
|||||
|
2023
Q4 | $11.5M | Sell |
|
|||||
|
2023
Q3 | $37.3M | Sell |
|
|||||
|
2023
Q2 | $96.1M | Buy |
|
|||||
|
2023
Q1 | $72.2M | Sell |
|
|||||
|
2022
Q4 | $141M | Buy |
|
|||||
|
2022
Q3 | $23M | Buy |
|
|||||
|
2022
Q2 | $966K | Sell |
|
|||||
|
2022
Q1 | $28.1M | Sell |
|
|||||
|
2021
Q4 | $23.5M | Buy |
|
|||||
|
2021
Q3 | $2.25M | Buy |
|
|||||
|
2021
Q2 | – | Hold |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $5.99M | Sell |
|
|||||
|
2020
Q1 | $44.7M | Buy |
|
|||||
|
2019
Q4 | $2.8M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $3.41M | Sell |
|
|||||
|
2019
Q1 | $6.47M | Buy |
|
|||||
|
2018
Q4 | $4.88M | Buy |
|
|||||
|
2018
Q3 | $4.64M | Buy |
|
|||||
|
2018
Q2 | $1M | Sell |
|
|||||
|
2018
Q1 | $41.7M | Buy |
|
|||||
|
2017
Q4 | $20.2M | Sell |
|
|||||
|
2017
Q3 | $82.6M | Sell |
|
|||||
|
2017
Q2 | $108M | Buy |
|
|||||
|
2017
Q1 | $13.2M | Buy |
|
|||||
|
2016
Q4 | $319K | Sell |
|
|||||
|
2016
Q3 | $431K | Buy |
|
|||||
|
2016
Q2 | $209K | Sell |
|
|||||
|
2016
Q1 | $546K | Sell |
|
|||||
|
2015
Q4 | $78.6M | Buy |
|
|||||
|
2015
Q3 | $51.2M | Buy |
|
|||||
|
2015
Q2 | $29.3M | Sell |
|
|||||
|
2015
Q1 | $50.3M | Buy |
|
|||||
|
2014
Q4 | – | Hold |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $5.17M | Buy |
|